Skip to contentJohnson John H — Xeris Biopharma Holdings, Inc. insider: 177 transactions · InsiderLensJohnson John H
- Director at Applied Therapeutics Inc. · on record since Dec 20, 2024
- Executive Chairman at Applied Therapeutics Inc. · on record since Dec 20, 2024
- CEO at IMCLONE SYSTEMS INC/DE · on record since Aug 29, 2007
- Director at IMCLONE SYSTEMS INC/DE · on record since Aug 28, 2008
- Sr. VP, Oncology Business Unit at LILLY ELI & CO · on record since Nov 10, 2009
- Director at SAVIENT PHARMACEUTICALS INC · on record since Feb 2, 2011
- Director at TRANZYME INC · on record since Apr 21, 2011
- Director at DENDREON CORP · on record since Aug 30, 2011
- Director at CEMPRA, INC. · on record since Mar 22, 2012
- Director at PORTOLA PHARMACEUTICALS INC · on record since Mar 27, 2014
- Chief Executive Officer at SAVIENT PHARMACEUTICALS INC · on record since Jan 4, 2012
- Director at LECTEC CORP /MN/ · on record since May 8, 2026
- Director at Verastem, Inc. · on record since May 26, 2026
- Pres & Chief Executive Officer at DENDREON CORP · on record since Feb 12, 2014
- Director at Xeris Biopharma Holdings, Inc. · on record since Jun 5, 2026
- Director at Sucampo Pharmaceuticals, Inc. · on record since Dec 15, 2014
- Director at Ocugen, Inc. · on record since Dec 2, 2014
- Director at AVEO PHARMACEUTICALS INC · on record since Feb 5, 2018
- Director at Strongbridge Biopharma plc · on record since Jan 2, 2018
- Chief Executive Officer at CEMPRA, INC. · on record since Feb 26, 2019
- Chief Executive Officer at Strongbridge Biopharma plc · on record since Nov 18, 2019
Insider trading activity of Johnson John H
- Transactions on record
- 177
- since Aug 29, 2007
- Open-market buys
- 9
- $758.8K
- Open-market sells
- 11
- $3.9M
- Companies traded
- 14
- last filing Jun 26, 2026
Figures computed from official regulatory filings — methodology.
Companies where Johnson John H has traded
- LECTEC CORP /MN/27 tx · $2.1M · Jun 26, 2026
- Xeris Biopharma Holdings, Inc.28 tx · $2.5M · Jun 5, 2026
- Verastem, Inc.16 tx · May 26, 2026
- Applied Therapeutics Inc.2 tx · Dec 20, 2024
- Strongbridge Biopharma plc13 tx · $936.8K · Oct 6, 2021
- PORTOLA PHARMACEUTICALS INC16 tx · $369.2K · Jul 2, 2020
- CEMPRA, INC.15 tx · $163.4K · Jul 2, 2019
- Ocugen, Inc.4 tx · Jun 19, 2018
- Sucampo Pharmaceuticals, Inc.9 tx · $327.1K · Feb 13, 2018
Track record of Johnson John H
Statistical track record
Free- Open-market buys
- 9
- Last buy
- May 23, 2014
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Johnson John H
Co-insiders of Johnson John H
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
1 tx · Feb 5, 2018
DePinto Joseph IDENDREON CORP +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 26, 2026 | AwardD | 4,392 | 0.00 USD | — | SEC |
| Jun 23, 2026 | Exercise | 14,150 | 0.00 USD | — | SEC |
| Jun 23, 2026 | ExerciseD | 14,150 | 0.00 USD | — | SEC |
| Jun 5, 2026 | AwardD | 32,996 | 6.15 USD | $202.9K | SEC |
| Jun 5, 2026 | Award | 24,193 | 0.00 USD | $0 | SEC |
| Jun 5, 2026 | Sell | -15,000 | 6.09 USD | $91.4K | SEC |
| May 26, 2026 | Award | 36,000 | 0.00 USD | $0 | SEC |
| May 8, 2026 | Sell | -11,050 | 43.26 USD | $478K | SEC |
| May 8, 2026 | ExerciseD | -11,050 | 0.00 USD | $0 | SEC |
| May 8, 2026 | Exercise | 11,050 | 7.04 USD | $77.8K | SEC |
| Dec 19, 2025 | Sell | -135,400 | 7.22 USD | $977.6K | SEC |
| Dec 10, 2025 | Exercise | 11,891 | 6.30 USD | $74.9K | SEC |
| Dec 10, 2025 | Exercise | 8,545 | 6.30 USD | $53.8K | SEC |
| Dec 10, 2025 | Sell | -11,891 | 31.22 USD | $371.2K | SEC |
| Dec 10, 2025 | Sell | -13,141 | 29.98 USD | $394K | SEC |
| Dec 10, 2025 | Sell | -11,802 | 31.26 USD | $368.9K | SEC |
| Dec 10, 2025 | Sell | -8,545 | 29.98 USD | $256.2K | SEC |
| Dec 10, 2025 | ExerciseD | -11,891 | 0.00 USD | $0 | SEC |
| Dec 10, 2025 | ExerciseD | -8,545 | 0.00 USD | $0 | SEC |
| Aug 15, 2025 | Sell | -107,500 | 7.32 USD | $786.9K | SEC |
| Jun 20, 2025 | AwardD | 14,150 | 0.00 USD | $0 | SEC |
| Jun 11, 2025 | Sell | -4,073 | 10.61 USD | $43.2K | SEC |
| Jun 4, 2025 | Award | 50,000 | 0.00 USD | $0 | SEC |
| May 27, 2025 | Award | 8,333 | 0.00 USD | $0 | SEC |
| May 27, 2025 | AwardD | 12,500 | 0.00 USD | $0 | SEC |